Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Gelesis

- PMLiVE

GSK preps COPD filing for asthma pioneer Nucala

Moves despite reporting mixed data for the treatment earlier this year

- PMLiVE

Ionis must go it alone as GSK ditches polyneuropathy drug

Inotersen’s side effects prompts pharma giant to relinquish rights

GSK hands new chief digital officer a transformative remit

Karenann Terrell will join the pharma firm from Walmart

- PMLiVE

GSK’s pipeline cull claims sirukumab, and possibly rare disease unit

Makeover designed to deliver a leaner, fitter company in 2020

- PMLiVE

Shake-up at GSK could claim antibiotics unit and UK facilities

The firm says its plans, which are expected to lead to 320 job cuts, are not related to Brexit

GSK signs up to apply AI to drug discovery

Will work with Exscientia on 10 small molecule targets

- PMLiVE

GSK signs up to apply AI to drug discovery

Will work with Exscientia on 10 small molecule targets

- PMLiVE

GSK starts trial of Nucala to seek alternate indications

Asthma therapy drug to be used to target severe nasal polyposis

- PMLiVE

GSK makes case for revaccination with Shingrix

The pharma giant seeks regulatory approval to treat people aged 50 plus

dengue fever mosquito

GSK cues up regulatory filings for relapsing malaria drug

60% of patients on tafenoquine combination remained relapse-free for six months

- PMLiVE

GSK’s Nucala posts mixed results in COPD

Conflicting late-stage trials throw doubt on its prospects

- PMLiVE

GSK asthma app wins healthcare technology award

Health Tech & You prizes also go to HealthUnlocked and others

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links